BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1294333)

  • 1. Bioavailability study of commercial sustained-release preparations of diclofenac sodium in gastrointestinal physiology regulated-dogs.
    Sagara K; Nagamatsu Y; Yamada I; Kawata M; Mizuta H; Ogawa K
    Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3303-6. PubMed ID: 1294333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal physiology-regulated dogs: utilization of a bioavailability study of a new thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]-diazepine, an antagonist of platelet-activating factor, and its preparations.
    Sagara K; Yamada I; Kawazoe Y; Mizuta H; Shibata M
    Biol Pharm Bull; 1994 Jan; 17(1):117-20. PubMed ID: 8148798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal physiology-regulated dogs for bioavailability evaluation of an oral controlled-release dosage form composed of pulsatile release granules.
    Sagara K; Yamada I; Matsuura Y; Kawata M; Shibata M
    Biol Pharm Bull; 1996 Sep; 19(9):1184-8. PubMed ID: 8889038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of gastrointestinal physiology regulated-dogs: bioavailability study of a commercial sustained-release dosage form of theophylline.
    Sagara K; Kawata M; Mizuta H; Shibata M
    Biol Pharm Bull; 1994 Jul; 17(7):931-4. PubMed ID: 8000380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of in-vitro release and bioavailability of sustained release diclofenac sodium from certain hydrophilic polymers and commercial tablets in beagle dogs.
    Hosny EA; al-Helw AR; al-Dardiri MA
    Pharm Acta Helv; 1997 Jun; 72(3):159-64. PubMed ID: 9204774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of radiotelemetric technique in evaluating diclofenac sodium absorption after oral administration of various dosage forms in healthy volunteers.
    Chan KK; Mojaverian P; Ziehmer BA; John VA
    Pharm Res; 1990 Oct; 7(10):1026-32. PubMed ID: 2281031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule.
    Koziolek M; Grimm M; Bollmann T; Schäfer KJ; Blattner SM; Lotz R; Boeck G; Weitschies W
    Eur J Pharm Biopharm; 2019 Mar; 136():221-230. PubMed ID: 30703546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of drug release rate on therapeutic outcomes: formulation dependence of gastrointestinal toxicity of diclofenac in the rat.
    Khazaeinia T; Jamali F
    Inflammopharmacology; 2004; 12(1):69-80. PubMed ID: 15035780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-scintigraphic study of the gastrointestinal transit and in vivo dissolution of a controlled release diclofenac sodium formulation in xanthan gum matrices.
    Billa N; Yuen KH; Khader MA; Omar A
    Int J Pharm; 2000 May; 201(1):109-20. PubMed ID: 10867269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric acidity-controlled beagle dogs.
    Yamada I; Goda T; Kawata M; Shiotuki T; Ogawa K
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3112-5. PubMed ID: 2085896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study on the relative bioavailability of a sustained-release formulation of diclofenac sodium.
    Suleiman MS; Najib N; el-Sayed Y; Hasan M; Abdulahameed M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):276-9. PubMed ID: 2737796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro and in vivo evaluations of oral sustained-release formulations of diclofenac sodium in beagle dogs.
    Medeiros DC; Mazon-Cardoso T; Lemos-Senna E; Poli A
    Pharmazie; 2009 Oct; 64(10):648-52. PubMed ID: 19947166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative bioavailability and pharmacokinetics of Dolotren retard and Dolotren].
    Honorato J; Montes B; Suárez J; Lucero ML; Valiente R
    Rev Med Univ Navarra; 1992; 37(1):7-16. PubMed ID: 1626168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative bioavailability study of a generic sustained release diclofenac sodium tablet.
    Magosso E; Yuen KH; Choy WP; Ling SS; Ng BH; Ur-Rahman N; Wong JW
    Med J Malaysia; 2004 Aug; 59(3):352-6. PubMed ID: 15727381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.
    Zmeili S; Hasan M; Najib N; Sallam E; Deleq S; Shubair M
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):564-70. PubMed ID: 8996854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of gastric acidity-controlled beagle dog to bioavailability study of cinnarizine].
    Yamada I; Goda T; Kawata M; Ogawa K
    Yakugaku Zasshi; 1990 Apr; 110(4):280-5. PubMed ID: 2376821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of food on the absorption of diclofenac as a pure substance.
    Terhaag B; Gramatte T; Hrdlcka P; Richter K; Feller K
    Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):418-21. PubMed ID: 1748542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in-vitro in-vivo evaluation of sustained release matrix diclofenac sodium tablets using PVP-K90 and natural gums.
    Iqbal Z; Khan R; Nasir F; Khan JA; Rashid A; Khan A; Khan A
    Pak J Pharm Sci; 2011 Oct; 24(4):435-43. PubMed ID: 21959802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the gastric absorption and emptying of drugs under various pH conditions using a simple intubation method: application to diclofenac.
    Vidon N; Pfeiffer A; Godbillon J; Rongier M; Gauron S; Hirtz J; Bernier JJ; Dubois JP
    Br J Clin Pharmacol; 1989 Jul; 28(1):121-4. PubMed ID: 2775611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and in vivo evaluation of diclofenac sodium sustained release matrix tablet: effect of compression force.
    Taha EI; Shazly GA; Harisa GI; Barakat NS; Al-Enazi FK; Elbagory IM
    Pak J Pharm Sci; 2015 Mar; 28(2):573-9. PubMed ID: 25730790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.